Search

everythinglearnresearchcommunity

for

Search:↓

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

The developed glycerosome gel improves minoxidil delivery for better alopecia treatment.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Modified stem cells from umbilical cord blood can make hair grow faster.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

Emotional symptoms from alopecia areata reduce work productivity and daily activity.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

People with skin conditions like psoriasis and eczema have higher anxiety levels.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Erdr1 could be a new marker for diagnosing hair loss.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Combining barber scalp care with medical treatment improves scalp health and well-being in early-stage alopecia.